Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.

Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, Terry P, Alberg AJ, Bandera EV, Funkhouser E, Wu AH, Pearce CL, Pike M, Setiawan VW, Haiman CA; African American Breast Cancer Consortium (AABC); African Ancestry Prostate Cancer Consortium (AAPC), Palmer JR, LeMarchand L, Wilkens LR, Berchuck A, Doherty JA, Modugno F, Ness R, Moysich K, Karlan BY, Whittemore AS, McGuire V, Sieh W, Lawrenson K, Gayther S, Sellers TA, Pharoah P, Schildkraut JM; African American Cancer Epidemiology Study (AACES); Ovarian Cancer Association Consortium (OCAC).

Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32653. [Epub ahead of print]

PMID:
31469419
2.

Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.

Mullins MA, Peres LC, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, Bondy ML, Funkhouser E, Moorman PG, Peters ES, Terry PD, Schwartz AG, Lawson AB, Schildkraut JM, Cote ML.

Cancer. 2019 Aug 15. doi: 10.1002/cncr.32451. [Epub ahead of print]

PMID:
31415710
3.

Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.

Schildkraut JM, Peres LC, Bethea TN, Camacho F, Chyn D, Cloyd EK, Bandera EV, Beeghly-Fadiel A, Lipworth L, Joslin CE, Davis FG, Moorman PG, Myers E, Ochs-Balcom HM, Setiawan VW, Pike MC, Wu AH, Rosenberg L.

Cancer Causes Control. 2019 Sep;30(9):967-978. doi: 10.1007/s10552-019-01199-7. Epub 2019 Jun 24.

PMID:
31236792
4.

Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma.

Peres LC, Hebert JR, Qin B, Guertin KA, Bandera EV, Shivappa N, Camacho TF, Chyn D, Alberg AJ, Barnholtz-Sloan JS, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Schildkraut JM.

J Nutr. 2019 Sep 1;149(9):1606-1616. doi: 10.1093/jn/nxz098.

PMID:
31152675
5.

Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study.

Ge J, Liu H, Qian D, Wang X, Moorman PG, Luo S, Hwang S, Wei Q.

Int J Cancer. 2019 Sep 1;145(5):1270-1279. doi: 10.1002/ijc.32371. Epub 2019 May 13.

PMID:
31026346
6.

Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.

Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, Hoyo C, Berchuck A, Sandler DP, Taylor JA, O'Brien KM, Velez Edwards DR, Edwards TL, Beeghly-Fadiel A, Wentzensen N, Pearce CL, Wu AH, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Modugno F, Ness R, Moysich K, Rossing MA, Doherty JA, Sellers TA, Permuth-Way JB, Monteiro AN, Levine DA, Setiawan VW, Haiman CA, LeMarchand L, Wilkens LR, Karlan BY, Menon U, Ramus S, Gayther S, Gentry-Maharaj A, Terry KL, Cramer DW, Goode EL, Larson MC, Kaufmann SH, Cannioto R, Odunsi K, Etter JL, Huang RY, Bernardini MQ, Tone AA, May T, Goodman MT, Thompson PJ, Carney ME, Tworoger SS, Poole EM, Lambrechts D, Vergote I, Vanderstichele A, Van Nieuwenhuysen E, Anton-Culver H, Ziogas A, Brenton JD, Bjorge L, Salvensen HB, Kiemeney LA, Massuger LFAG, Pejovic T, Bruegl A, Moffitt M, Cook L, Le ND, Brooks-Wilson A, Kelemen LE, Pharoah PDP, Song H, Campbell I, Eccles D, DeFazio A, Kennedy CJ, Schildkraut JM.

Cancer Med. 2019 May;8(5):2503-2513. doi: 10.1002/cam4.1996. Epub 2019 Apr 18.

7.

Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.

Guo Y, Feng Y, Liu H, Luo S, Clarke JW, Moorman PG, Su L, Shen S, Christiani DC, Wei Q.

Mol Carcinog. 2019 Jul;58(7):1094-1104. doi: 10.1002/mc.23017. Epub 2019 Apr 15.

PMID:
30989732
8.

Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.

Chen K, Liu H, Liu Z, Luo S, Patz EF Jr, Moorman PG, Su L, Shen S, Christiani DC, Wei Q.

Int J Cancer. 2019 Aug 1;145(3):621-631. doi: 10.1002/ijc.32128. Epub 2019 Feb 1.

PMID:
30650190
9.

Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.

Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, Butzow R, Campbell IG, Chang-Claude J, Chen K, Cook LS, Cramer DW, deFazio A, Dennis J, Doherty JA, Dörk T, Eccles DM, Edwards DV, Fasching PA, Fortner RT, Gayther SA, Giles GG, Glasspool RM, Goode EL, Goodman MT, Gronwald J, Harris HR, Heitz F, Hildebrandt MA, Høgdall E, Høgdall CK, Huntsman DG, Kar SP, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Koushik A, Lambrechts D, Le ND, Levine DA, Massuger LF, Matsuo K, May T, McNeish IA, Menon U, Modugno F, Monteiro AN, Moorman PG, Moysich KB, Ness RB, Nevanlinna H, Olsson H, Onland-Moret NC, Park SK, Paul J, Pearce CL, Pejovic T, Phelan CM, Pike MC, Ramus SJ, Riboli E, Rodriguez-Antona C, Romieu I, Sandler DP, Schildkraut JM, Setiawan VW, Shan K, Siddiqui N, Sieh W, Stampfer MJ, Sutphen R, Swerdlow AJ, Szafron LM, Teo SH, Tworoger SS, Tyrer JP, Webb PM, Wentzensen N, White E, Willett WC, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J.

Cancer Res. 2019 Feb 1;79(3):505-517. doi: 10.1158/0008-5472.CAN-18-2726. Epub 2018 Dec 17.

PMID:
30559148
10.

Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women.

Moorman PG, Barrett NJ, Wang F, Alberg JA, Bandera EV, Barnholtz-Sloan JB, Bondy M, Cote ML, Funkhouser E, Kelemen LE, Peres LC, Peters ES, Schwartz AG, Terry PD, Crankshaw S, Abbott SE, Schildkraut JM.

J Womens Health (Larchmt). 2019 Apr;28(4):444-451. doi: 10.1089/jwh.2018.7031. Epub 2018 Nov 27.

PMID:
30481095
11.

Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study.

Anderson RT, Peres LC, Camacho F, Bandera EV, Funkhouser E, Moorman PG, Paddock LE, Peters ES, Abbott SE, Alberg AJ, Barnholtz-Sloan J, Bondy M, Cote ML, Schwartz AG, Terry P, Schildkraut JM.

J Womens Health (Larchmt). 2019 Feb;28(2):284-293. doi: 10.1089/jwh.2018.7025. Epub 2018 Oct 10.

PMID:
30307782
12.

Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.

Park HK, Schildkraut JM, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, Bondy M, Crankshaw S, Funkhouser E, Moorman PG, Peters ES, Terry P, Wang F, Ruterbusch JJ, Schwartz AG, Cote ML.

Cancer Causes Control. 2018 Nov;29(11):1081-1091. doi: 10.1007/s10552-018-1082-4. Epub 2018 Sep 29.

PMID:
30269307
13.

Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.

Qian D, Liu H, Wang X, Ge J, Luo S, Patz EF Jr, Moorman PG, Su L, Shen S, Christiani DC, Wei Q.

Int J Cancer. 2019 Apr 15;144(8):1867-1876. doi: 10.1002/ijc.31896. Epub 2018 Dec 8.

PMID:
30259978
14.

Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.

Freedman JA, Wang Y, Li X, Liu H, Moorman PG, George DJ, Lee NH, Hyslop T, Wei Q, Patierno SR.

Carcinogenesis. 2018 Jul 3;39(7):879-888. doi: 10.1093/carcin/bgy062.

15.

Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Peres LC, Risch H, Terry KL, M Webb P, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Anne Rossing M, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium.

Int J Epidemiol. 2018 Mar 23. doi: 10.1093/ije/dyy054. [Epub ahead of print] No abstract available.

16.

Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).

Mills AM, Peres LC, Meiss A, Ring KL, Modesitt SC, Abbott SE, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Wallace K, Schildkraut JM.

Int J Gynecol Pathol. 2019 Mar;38(2):157-170. doi: 10.1097/PGP.0000000000000494.

PMID:
29485423
17.

Engaging African Americans in Research: The Recruiter's Perspective.

Barrett NJ, Ingraham KL, Vann Hawkins T, Moorman PG.

Ethn Dis. 2017 Dec 7;27(4):453-462. doi: 10.18865/ed.27.4.453. eCollection 2017 Fall.

18.

Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium.

Int J Epidemiol. 2018 Apr 1;47(2):460-472. doi: 10.1093/ije/dyx252. Erratum in: Int J Epidemiol. 2018 Mar 23;:.

19.

Recreational physical activity and survival in African-American women with ovarian cancer.

Abbott SE, Camacho F, Peres LC, Alberg AJ, Bandera EV, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peters ES, Qin B, Schwartz AG, Barnholtz-Sloan J, Terry P, Schildkraut JM.

Cancer Causes Control. 2018 Jan;29(1):77-86. doi: 10.1007/s10552-017-0986-8. Epub 2017 Nov 29.

PMID:
29188593
20.

Tubal ligation and ovarian cancer risk in African American women.

McNamara C, Abbott SE, Bandera EV, Qin B, Peres LC, Camacho F, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Schildkraut JM, Terry P.

Cancer Causes Control. 2017 Oct;28(10):1033-1041. doi: 10.1007/s10552-017-0943-6. Epub 2017 Sep 4.

PMID:
28871344
21.

Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.

DeBono NL, Robinson WR, Lund JL, Tse CK, Moorman PG, Olshan AF, Troester MA.

J Womens Health (Larchmt). 2018 Mar;27(3):377-386. doi: 10.1089/jwh.2016.6063. Epub 2017 Jun 1.

22.

Dietary Quality and Ovarian Cancer Risk in African-American Women.

Qin B, Moorman PG, Kelemen LE, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM, Bandera EV.

Am J Epidemiol. 2017 Jun 15;185(12):1281-1289. doi: 10.1093/aje/kwx022.

23.

Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.

Wang Y, Freedman JA, Liu H, Moorman PG, Hyslop T, George DJ, Lee NH, Patierno SR, Wei Q.

Int J Cancer. 2017 Aug 15;141(4):731-743. doi: 10.1002/ijc.30787. Epub 2017 Jun 1.

24.

Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).

Kelemen LE, Abbott S, Qin B, Peres LC, Moorman PG, Wallace K, Bandera EV, Barnholtz-Sloan JS, Bondy M, Cartmell K, Cote ML, Funkhouser E, Paddock LE, Peters ES, Schwartz AG, Terry P, Alberg AJ, Schildkraut JM.

Cancer Causes Control. 2017 Jul;28(7):699-708. doi: 10.1007/s10552-017-0899-6. Epub 2017 May 2.

25.

Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.

Peres LC, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Abbott SE, Camacho F, Wang F, Schildkraut JM.

Am J Epidemiol. 2017 Jul 1;186(1):46-53. doi: 10.1093/aje/kwx055.

26.

Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.

Peres LC, Moorman PG, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry PD, Abbott SE, Camacho F, Wang F, Schildkraut JM.

Cancer Causes Control. 2017 May;28(5):405-414. doi: 10.1007/s10552-017-0853-7. Epub 2017 Mar 2.

27.

Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women.

Terry PD, Qin B, Camacho F, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Guertin KA, Peters ES, Schwartz AG, Schildkraut JM, Bandera EV.

J Nutr. 2017 Apr;147(4):621-627. doi: 10.3945/jn.116.243279. Epub 2017 Feb 15.

28.

Dairy, calcium, vitamin D and ovarian cancer risk in African-American women.

Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM, Bandera EV.

Br J Cancer. 2016 Oct 25;115(9):1122-1130. doi: 10.1038/bjc.2016.289. Epub 2016 Sep 15.

29.

Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.

Peres LC, Bandera EV, Qin B, Guertin KA, Shivappa N, Hebert JR, Abbott SE, Alberg AJ, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Camacho F, Wang F, Schildkraut JM.

Int J Cancer. 2017 Feb 1;140(3):535-543. doi: 10.1002/ijc.30467. Epub 2016 Nov 14.

30.

In Reply.

Trabuco EC, Moorman PG, Cliby WA.

Obstet Gynecol. 2016 Sep;128(3):655-6. doi: 10.1097/AOG.0000000000001607. No abstract available.

PMID:
27548538
31.

Reproductive factors and ovarian cancer risk in African-American women.

Moorman PG, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Crankshaw S, Wang F, Schildkraut JM.

Ann Epidemiol. 2016 Sep;26(9):654-62. doi: 10.1016/j.annepidem.2016.07.004. Epub 2016 Jul 18.

32.

Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study.

Alberg AJ, Moorman PG, Crankshaw S, Wang F, Bandera EV, Barnholtz-Sloan JS, Bondy M, Cartmell KB, Cote ML, Ford ME, Funkhouser E, Kelemen LE, Peters ES, Schwartz AG, Sterba KR, Terry P, Wallace K, Schildkraut JM.

Am J Epidemiol. 2016 Aug 15;184(4):274-83. doi: 10.1093/aje/kwv450. Epub 2016 Aug 3.

33.

Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).

Schildkraut JM, Abbott SE, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, Bondy ML, Cote ML, Funkhouser E, Peres LC, Peters ES, Schwartz AG, Terry P, Crankshaw S, Camacho F, Wang F, Moorman PG.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1411-1417. Epub 2016 May 12.

34.

Association of Ovary-Sparing Hysterectomy With Ovarian Reserve.

Trabuco EC, Moorman PG, Algeciras-Schimnich A, Weaver AL, Cliby WA.

Obstet Gynecol. 2016 May;127(5):819-27. doi: 10.1097/AOG.0000000000001398.

35.

Obesity, weight gain, and ovarian cancer risk in African American women.

Bandera EV, Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM.

Int J Cancer. 2016 Aug 1;139(3):593-600. doi: 10.1002/ijc.30115. Epub 2016 Apr 15.

36.

Recreational physical activity and ovarian cancer risk in African American women.

Abbott SE, Bandera EV, Qin B, Peres LC, Moorman PG, Barnholtz-Sloan J, Schwartz AG, Funkhouser E, Peters ES, Cote ML, Alberg AJ, Terry P, Bondy M, Paddock LE, Crankshaw S, Wang F, Camacho F, Schildkraut JM.

Cancer Med. 2016 Jun;5(6):1319-27. doi: 10.1002/cam4.677. Epub 2016 Feb 29.

37.

Analgesic medication use and risk of epithelial ovarian cancer in African American women.

Peres LC, Camacho F, Abbott SE, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Crankshaw S, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry P, Wang F, Schildkraut JM.

Br J Cancer. 2016 Mar 29;114(7):819-25. doi: 10.1038/bjc.2016.39. Epub 2016 Feb 23.

38.

The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer.

Erondu CO, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters E, Schwartz AG, Terry PD, Wallace K, Akushevich L, Wang F, Crankshaw S, Berchuck A, Schildkraut JM, Moorman PG.

J Womens Health (Larchmt). 2016 Jun;25(6):571-8. doi: 10.1089/jwh.2015.5359. Epub 2016 Feb 17.

39.

Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Le ND, Cook LS, Kelemen LE, Brooks-Wilson A, Massuger LF, Kiemeney LA, Aben KK, van Altena AM, Houlston R, Tomlinson I, Palmieri RT, Moorman PG, Schildkraut J, Iversen ES, Phelan C, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Kruger-Kjaer S, Blaeker J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Butzow R, Nevanlinna H, Leminen A, Bogdanova N, Antonenkova N, Doerk T, Hillemanns P, Dürst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen C, Rafnar T, Besenbacher S, Sulem P, Stefansson K, Birrer MJ, Terry KL, Hernandez D, Cramer DW, Vergote I, Amant F, Lambrechts D, Despierre E, Fasching PA, Beckmann MW, Thiel FC, Ekici AB, Chen X; Australian Ovarian Cancer Study Group, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas M, Sellers T, Easton DF, Berchuck A, Chenevix-Trench G, Pharoah PD, Gayther SA.

Nat Genet. 2016 Jan;48(1):101. doi: 10.1038/ng0116-101b. No abstract available.

PMID:
26711112
40.

Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women.

Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM, Bandera EV.

Br J Nutr. 2016 Feb 28;115(4):694-702. doi: 10.1017/S0007114515004882. Epub 2015 Dec 16.

41.

Should women at high risk for cancer use oral contraceptive pills?

Moorman PG.

Per Med. 2015 Nov;12(6):533-535. doi: 10.2217/pme.15.36. Epub 2015 Nov 3. No abstract available.

PMID:
29750608
42.

A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES).

Schildkraut JM, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters E, Schwartz AG, Terry P, Wallace K, Akushevich L, Wang F, Crankshaw S, Moorman PG.

BMC Cancer. 2014 Sep 22;14:688. doi: 10.1186/1471-2407-14-688.

43.

Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.

Allott EH, Tse CK, Olshan AF, Carey LA, Moorman PG, Troester MA.

Breast Cancer Res Treat. 2014 Sep;147(2):415-21. doi: 10.1007/s10549-014-3099-z. Epub 2014 Aug 24.

44.

Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.

Davidson BA, Moorman PG.

Expert Opin Drug Saf. 2014 Oct;13(10):1375-82. doi: 10.1517/14740338.2014.951327. Epub 2014 Aug 22. Review.

PMID:
25146351
45.

Challenges and Recommendations to Recruiting Women Who Do Not Adhere to Follow-Up Gynecological Care.

Wordlaw-Stinson L, Jones S, Little S, Fish L, Vidal A, Smith JS, Hoyo C, Moorman PG.

Open J Prev Med. 2014 Mar 20;4(3):123-128.

46.

The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.

Gaines AR, Turner EL, Moorman PG, Freedland SJ, Keto CJ, McPhail ME, Grant DJ, Vidal AC, Hoyo C.

Cancer Causes Control. 2014 Aug;25(8):1029-35. doi: 10.1007/s10552-014-0402-6. Epub 2014 May 31.

47.

Long-term risk of medical conditions associated with breast cancer treatment.

Hill DA, Horick NK, Isaacs C, Domchek SM, Tomlinson GE, Lowery JT, Kinney AY, Berg JS, Edwards KL, Moorman PG, Plon SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM.

Breast Cancer Res Treat. 2014 May;145(1):233-43. doi: 10.1007/s10549-014-2928-4. Epub 2014 Apr 3.

48.

Oral contraceptive use for the primary prevention of ovarian cancer.

Havrilesky LJ, Gierisch JM, Moorman PG, Coeytaux RR, Urrutia RP, Lowery WJ, Dinan M, McBroom AJ, Wing L, Musty MD, Lallinger KR, Hasselblad V, Sanders GD, Myers ER.

Evid Rep Technol Assess (Full Rep). 2013 Jun;(212):1-514. Review.

49.

Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.

Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Peragallo Urrutia R, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER.

J Clin Oncol. 2013 Nov 20;31(33):4188-98. doi: 10.1200/JCO.2013.48.9021. Epub 2013 Oct 21. Review.

PMID:
24145348
50.

Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.

Allott EH, Abern MR, Gerber L, Keto CJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Moorman PG, Freedland SJ.

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):391-7. doi: 10.1038/pcan.2013.48. Epub 2013 Oct 8.

Supplemental Content

Loading ...
Support Center